The global diabetic foot ulcer treatment market size is expected to reach a value of USD 6.82 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.2% during the forecast period. Rising prevalence of diabetes, increasing healthcare expenses, and rapidly growing geriatric population worldwide are some of the major factors driving the diabetic foot ulcer treatment market.
Diabetic
foot ulcers are one of the most common foot injuries that is caused due to
diabetes mellitus. Management of diabetic foot ulcers aims at fast healing and
wound closure, by adopting a multidisciplinary therapeutic approach so as to
avoid amputation. Among different types of treatment options available,
biologics held the largest share in the diabetic foot ulcer treatment market in
2017. This can be attributed to strong revenue generated by growth factors that
are prescribed worldwide for their ability to promote generation of new cells
and achieve wound closure. Therapy devices and wound care dressings also offer
significant commercial opportunity due to their cost-effectiveness, ease of
availability, and wide use in combination with other treatments at every level
of wound care management.
Among
different ulcer types, neuro-ischemic ulcers led the market in 2017 with more
than 50.0% market share due to higher patient population suffering from the
ulcer type globally. North America represented the largest share in the global
market in 2017 owing to rising prevalence of diabetes, growing geriatric
cohort, increased investment in R&D of novel therapies, and developed
healthcare facilities.
For more info visit here: https://www.grandviewresearch.com/industry-analysis/diabetic-foot-ulcer-dfu-treatment-market
Diabetic Foot
Ulcer Treatment Market Report Highlights
- The biologics
segment commanded the largest share in 2017 and is projected to retain its
position through the forecast period, due to increased adoption and
potential approvals of growth factors
- North America
dominated the DFU treatment market in 2017 due to well-established
favorable healthcare reimbursements and infrastructure
- Asia Pacific
is expected to witness the fastest growth owing to expanding diabetes
patient population driven by increasing healthcare expenses and growing
geriatric cohort
- The
neuro-ischemic ulcers segment accounted for the leading share in 2017. It
is likely to experience the fastest growth during the forecast period
- The foam and
alginate dressings, skin grafts, and negative pressure wound therapy
segments are anticipated to exhibit significant CAGR over the forecast
period
- Some of the
key players in this space are ConvaTec, Inc.; Acelity L.P. Inc.; 3M
Healthcare; Coloplast A/S; Smith & Nephew Plc.; B. Braun Melsungen AG;
Medline Industries, Inc.; Medtronic Plc.; Organogenesis, Inc.; Molnlycke
Health Care AB; and BSN Medical GMBH.
Diabetic Foot
Ulcer Treatment Market Segmentation
Grand View Research has
segmented the global diabetic foot ulcer (DFU) treatment market on the basis of
treatment, ulcer type, and region:
Diabetic Foot
Ulcer (DFU) Treatment Outlook (Revenue, USD Million, 2016 - 2025)
- Wound Care Dressings
- Alginate Dressings
- Hydrofiber Dressings
- Foam Dressings
- Film Dressing
- Hydrocolloid Dressings
- Surgical Dressings
- Hydrogel Dressings
- Biologics
- Growth Factors
- Skin Grafts
- Therapy Devices
- Negative Pressure Wound Therapy
- Ultrasound Therapy
- Antibiotic Medications
- Others
Diabetic Foot
Ulcer (DFU) Treatment Ulcer Type Outlook (Revenue, USD Million,
2016 - 2025)
- Neuropathic Ulcers
- Ischemic Ulcers
- Neuro-ischemic Ulcers
Diabetic Foot
Ulcer (DFU) Treatment Region Outlook (Revenue, USD Million, 2016 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/diabetic-foot-ulcer-dfu-treatment-market/request/rs1
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com